Dissertation > Excellent graduate degree dissertation topics show

Effects of Chongcao Shencha Capsule on Expression of the ECM and TIMP-1mRNA in Rat Glomerulosclerosis

Author: YuSiMing
Tutor: SongLiQun
School: Heilongjiang University of Traditional Chinese Medicine
Course: Chinese medical science
Keywords: Congcao Shencha capsule Glomerulosclerosis Extracelluar matrix Plasminogen activator inhibitor-1 Tissue inhibitors of metalloproteinases-1
CLC: R285.5
Type: PhD thesis
Year: 2008
Downloads: 143
Quote: 0
Read: Download Dissertation

Abstract


Objective:To investigate nephroprotective effects and mechanism of CongCaoShenCha capsule in rat forepart glomerulosclerosis induced by adriamy cin.Methods:72 wistar rats were randomly divided into 4 groups:Sham operation group,non-treated nephropathy group,CongCaoShenCha capsule group, Fosinopril Sodium group,glomerulosclerosis rats model were induced by unilateral nephrectomy and injecting adriamycin.The model and normal group were fed with normal food,while the treated group were intraga -stricly fed with CongCaoShenCha capsule(0.47g·kg-1·d-1)and Fosinopril Sodium group(7.5mg·kg-1·d-1).then the each group was divided randomly into different time points of weeks 6,8,10,and12 to observe urinary protein;BUN,Scr,TP,Alb,Chol,LDL and TG were measured after 8 and12 weeks.All rats were killed in the 12 week, pathological changes were observed by light microscopy and glomerulosclerosis index(GSI)were counted.Immunohistochemistry was used to examine connective tissue growth factor(CTGF),Fibronectin (FN),collagenⅣ(Col-Ⅳ),plasminogen activator inhibitor-1(FAI-1), Matrixmetallopro teinases-2(MMP-2),monocyte chemoattractant protein-1(MCP-1),pla sminogen activator inhibitor-1(PAI-1).The semiquantitative PCR was used to detect the expression of TIMP-1 mRNA.Result:1.Compared with non-treated nephropathy group,urinary protein were decreased at weeks 8,10and12(P<0.01).2.Compared with non-treated nephropathy group,BUN and Scr of CongCaoShenCha capsule were decreased at weeks 8and12(P<0.01), while TP,Alb were increased at week 12(P<0.01). 3.50 percent glomeruli suffering different degree sclerosis in non-tre ated nephropathy group,it show localized glomerulosclerosis,interstitial fibrosis and localized ymphocyte and monocyte soakage.Pathohistologi cal study revealed that CongCaoShenCha capsule group had the least renal lesions in terms of glomerulosclerosis compared with the other groups,and glomerulosclerosis index(GSI)is much higher in non-treated nephropathy group.4.According to immunohistochemical result in CongCaoShenCha capsule group and Fosinopril Sodium group,he expression of CTGF,FN, Col-Ⅳwas Stronger in non-treated nephropathy group(P<0.05).5.The expression of PAI-1 and MCP-lwas weaker in non-treated nephropathy group(P<0.05,P<0.01),but MMP-2 was stronger.6.The expression of TIMP-1mRNA was weaker in Fosinopril Sodium group and CongCaoShenCha capsule-treated group,the later was the weakest(P<0.05).Conclusion:CongCaoShenCha capsule not only reduced proteinuria,improves renal function,but also degraded the expression of PAI-1,MCP-1 and TIMP-1mRNA in kidney,and inhibited glomerulosclerosis.

Related Dissertations

  1. Based on the tutor clinical experience in medical treatment of chronic kidney disease proteinuria,R277.5
  2. Differential Expression of Plasminogen Activator Inhibitor-1 in Hypertrophic Scar Versus Normal Skin,R622
  3. Application of Urokinase-type Plasminogen Activator (uPA) in Diagnosis of Breast Cancer in Women,R737.9
  4. Research on the Role of γ-GCS in the Interstitial Fibrosis of Lupus Nephritis,R593.242
  5. Kidney and spleen, Xiezhuo stasis treatment of chronic renal failure in clinical and experimental research,R277.5
  6. Study the Dynamical Fluctuation of the Fibrinolytic Activity in Patients with Mini-invasive Hematoma Aspiration,R743.34
  7. Expression and Clinical Significance of PAI-1 in the Renal Biopsy of Patients with CKD,R692
  8. Abnormality of Fibrinolysis System and Endothelin-1 in Patients with Chronic Obstructive Pulmonary Disease and the Relationship of C-reactive Protein with Them,R563.9
  9. The Expressions of MMP-2, -9 and TIMP-1, -2 after the Expression of VEGF Suppressed by siRNA in Human Tongue Squamous Cell Carcinoma in Vitro and in Vivo,R739.8
  10. 1.Studies on Synergistic Effect and Mechanism of Up-regulation of Plasminogen Activator Inhibitor-1 by Glucocorticoid and Transforming Growth Factor-β1 in Ovarian Cancer HO-8910 Cells 2.Hypoxia Up-regulates the Expression of Stomation in Cerebral Cortex o,R737.31
  11. Valsartan cirrhosis and portal hypertension clinical study,R575.2
  12. The Significance of Intrapleural Pingyangmycin Administration on PAI-1、t-PA and TGF-β1 of Malignant Pleural Effusion,R730.5
  13. Research Progress of Plasminogen Activator Inhibitor One in Gestational Diabetes Mellitus,R587.1
  14. Variations of TF, ATⅢ, PAI-1 and APC% Levels in the Blood of Patients with Severe Multiple-Trauma and Their Function to Prevent the Occurrence of Pre-DIC,R554.8
  15. Effect of Ghrelin on CLP-induced ALI in Mice and the Signal Pathways Involved in the Modulation,R563.8
  16. Clinical and Experimental Study on Chronic Renal Failure with Total Saponins of Panax Notoginseseng,R277.5
  17. Relationship between Plasma Urokinase-type Plasminogen Activator(uPA) and Plasminogen Activator Inhibitor(PAI-1) Level and Biological Behaviors in the Breast Cancer Patients,R737.9
  18. The Serum Levels of Inflammatory Factors as Well as the Effect by Insulin Pump Treatment on Factors in Newly Diagnosed Type 2 Diabetic Patients,R587.1
  19. Plasma fibrinolytic activity , of triglycerides with acute coronary syndrome clinical correlation,R541.4
  20. Relationship fibrinolytic system with Kawasaki disease coronary artery lesions,R725.4
  21. The Relationship of the Change in Fibrinolytic System and Vascular Endothelial Growth Factor with Infiltration in Non-Hodgkin’s Lymphoma,R733.1

CLC: > Medicine, health > Chinese Medicine > Of Pharmacy > Pharmacology > Chinese medicine Experimental Pharmacology
© 2012 www.DissertationTopic.Net  Mobile